Medical device company Motus GI Holdings priced its initial public offering late Tuesday at $5 a share, the low end of its $5 to $7 price range. The Israeli company sold 3.5 million shares to raise $18.5 million. The company was originally planning to offer 4.3 million shares but reduced the size of the deal ahead of pricing. Motus will start trading on Nasdaq later Wednesday under the ticker symbol “MOTS.” Piper Jaffray and Oppenheimer were joint bookrunners on the deal.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News